NDPSC record of reasons, 36th meeting, 25-26 February 2003
National Drugs and Poisons Schedule Committee
The Record of the Reasons contains the basis of scheduling decisions and other outcomes arising from the meeting. Please note that the Record of the Reasons includes extracts from the NDPSC minutes which have been edited to remove confidential information.
*Large file warning: Attempting to open large pdf files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
NDPSC Record of reasons Meeting 37, 25-26 February 2003 (pdf,527kb)
Contents
Glossary
2. Proposed changes/additions to Parts 1 to 3 and Part 5 of the Standard for the Uniform Scheduling of Drugs and Poisons
- 2.1 SUSDP, Part 1
- 2.2 SUSDP, Part 2
- 2.3 SUSDP, Part 3
- 2.3.1 Organotin Compounds
- 2.4.1 Boron trifluoride, bifluorides and hydrosilicofluoric acid - Appendix F Part 3
Agricultural/veterinary, industrial and domestic chemicals
3. Matters arising from the minutes of the previous meeting (consideration of post-meeting submissions under 42ZCZ)
- 3.1 Flumioxazin
- 3.2 Chlorinating compounds
- 3.3 Extract of lemon eucalyptus
4. Other outstanding matters from previous meetings
- 4.1 Variation of requirement for Clause 7(1)(D)
- 4.2 Appendix B
- 4.3 Lithium in pigments
5. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons
- 5.2 SUSDP, Part 5
- 5.2.1 Sodium Hydroxide
- 5.3 Warning statements and general safety directions established by CPAS for agricultural and veterinary chemicals (standing agenda item)
6. Matters referred by the National Registration Authority for Agricultural and Veterinary Chemicals
- 6.1 Fenbuconazole
- 6.2 Morantel tartrate
- 6.3 Bacillus sphaericus strain 2362
- 6.4 Cadusafos
- 6.5 Marbofloxacin
- 6.6 Ivermectin
7. Matters referred by Scientific Director of the Non-Prescription Medicines Branch
8. Antibiotics for consideration following recommendations of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR)
- 8.1 Virginiamycin
- 8.2 Bacitracin
- 8.3 Cuprimyxin
- 8.4 Erythromycin
- 8.5 Hygromycin
- 8.6 Nalidixic acid
- 8.7 Nisin
- 8.8 Spiramycin
- 8.9 Avoparcin
9. Other matters for consideration
10. Initial review and/or formal opinions (ag/vet, industrial & domestic chemicals
11. Information items (ag/vet, industrial & domestic chemicals)
Pharmaceuticals
12. Matters arising from the minutes of the previous meeting (consideration of post-meeting submissions under 42ZCZ)
- 12.1 Azadirachta indica (neem)
- 12.2 Polyacrylamide
13. Other outstanding matters from previous meetings
- 13.1 Clobetasone, alclometasone and hydrocortisone
- 13.2 Pseudoephedrine
- 13.3 Collagen, hyaluronic acid, polylactic acid
- 13.4 Iron compounds
- 13.5 (Deleted)
- 13.6 Oxedrine
14. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons
- 14.1 SUSDP, Part 4
- 14.1.1 Lansoprazole
- 14.1.2 Ketoprofen
- 14.1.3 Dextromethorphan
- 14.1.4 Orlistat
- 14.1.5 Nabilone
- 14.1.6 beclomethasone
- 14.1.7 Mitragynine
- 14.2 SUSDP, Part 5
- 14.2.1 Appendix H
- 14.2.1.1 Sodium Phosphate
15. Matters referred by the Australian Drug Evaluation Committee (ADEC)
- 15.1 New substances
- 15.1.1 Tadalafil
- 15.1.2 Etoricoxib
- 15.1.3 Valdecoxib
- 15.1.4 Pegfilgrastim
- 15.1.5 Telithromycin
- 15.1.6 Bosentan
- 15.1.7 Dutasteride
- 15.2 For information (substances already scheduled)
16. Other matters for consideration
- 16.1 Dextromethorphan
- 16.2 3-Aminobenzoic acid ethyl ester methanesulphonate
- 16.3 Orthocaine
- 16.4 Benzamine
- 16.5 Ibuprofen
- 16.6 Selenium
- 16.7 Silver sulfadiazine
17. Matters referred by the Medicines Evaluation Committee (MEC)
18. Matters referred by the Medicines Classification Committee (MCC) of New Zealand
- 18.1 Sodium picosulfate
- 18.2 Solanaceous plants and alkaloids
- 18.3 Glyceryl trinitrate & isosorbide dinitrate
- 18.4 Nicotine for inhalation
- 18.5 Clobetasone